002680SZSE

Announcement on the Progress of the Company's Investigation by the China Securities Regulatory Commission and Risk Warning

Changsheng Retreat Co., Ltd.·August 9, 2019·2 pages

✨ AI Summary

The company, Changsheng Biotechnology Co., Ltd., is under investigation by the China Securities Regulatory Commission for failing to disclose its 2018 annual report on time. The investigation began on May 10, 2019, and the company has not yet received any conclusive findings. During this period, the company will cooperate with the investigation and provide monthly updates on the situation and potential risks of stock suspension.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Changsheng Biotechnology Co., Ltd.
Securities Code: 002680
Securities Abbreviation: *ST Changsheng
Announcement No.: 2019-040

Changsheng Biotechnology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

On May 10, 2019, the Company received the "Investigation Notice" (Su Zheng Diao Cha Zi 2019035) from the China Securities Regulatory Commission (hereinafter referred to as "CSRC") due to the failure to disclose the 2018 annual report within the statutory period, leading to the initiation of an investigation.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.